A surprising potential new use for Viagra is emerging: researchers have found the active ingredient in the medication may alleviate symptoms of Leigh syndrome, a rare and devastating genetic disorder. The findings, published in the journal Cell, offer a glimmer of hope for those affected by this currently incurable condition. This discovery highlights the potential for repurposing existing drugs to treat rare diseases.
What is Leigh Syndrome?
Leigh syndrome is a severe neurological disorder that typically manifests in infancy or early childhood. “Leigh syndrome is part of the mitochondrial diseases, which are disorders of energy metabolism,” explained researchers involved in the study. Mitochondria are the powerhouses of cells, and genetic mutations that disrupt their function can lead to brain damage. Symptoms vary depending on the area of the brain affected, but commonly include muscle weakness, difficulty swallowing, breathing problems, seizures, and developmental delays. Sadly, individuals with Leigh syndrome have a reduced life expectancy, and We find currently no curative treatments available.
How Viagra Became a Potential Treatment for Leigh Syndrome
The investigation into sildenafil – the active ingredient in Viagra – began with a broad screening of over 5,500 existing drugs. Researchers first created stem cells from the skin cells of patients with Leigh syndrome, allowing them to generate nerve cells that mirrored the disease’s characteristics. They then tested the effects of various compounds on these nerve cells in a laboratory setting. “This demonstrated that sildenafil, among other drugs, improved the electrical functionality of nerve cells,” said Dr. Ole Pless, the lead author of the study.
Further research involved the use of organoids – miniature, three-dimensional replicas of the brain – to confirm sildenafil’s benefits on nerve cells. Studies in animals showed the drug improved energy metabolism and extended lifespan. These promising preclinical results paved the way for a small clinical trial.
A German research team enrolled six patients with Leigh syndrome, ranging in age from 9 months to 38 years, in a trial where all participants received sildenafil. Over several months, improvements in muscle strength were observed, and in some cases, neurological symptoms subsided. Patients also demonstrated a faster recovery from metabolic crises – episodes of energy metabolism overload that can worsen the disease. “For example, one child treated with sildenafil increased their walking distance tenfold, from 500 to 5,000 meters,” noted Professor Markus Schuelke, a co-author of the study. “In another child, the treatment completely eliminated monthly metabolic crises, while another patient no longer experienced epileptic seizures.”
Future Clinical Studies to Confirm Viagra’s Role in Treating Leigh Syndrome
While these initial findings are encouraging, researchers emphasize the necessitate for larger, more comprehensive studies. The rarity of Leigh syndrome – affecting approximately 1 in 36,000 individuals – presents a significant challenge to research efforts. “The low number of cases complicates research into this disease and represents an obstacle in our urgent quest for effective treatments,” continued Markus Schuelke. However, these results may qualify sildenafil for orphan drug status, which streamlines the approval process for treatments targeting rare diseases. To further validate these findings, the European research team plans to conduct a placebo-controlled clinical trial.
